Nutex Health Inc.
NUTX
$90.28
-$15.06-14.30%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 151.68M | 267.80M | 243.99M | 211.79M | 257.62M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 151.68M | 267.80M | 243.99M | 211.79M | 257.62M |
| Cost of Revenue | 93.85M | 107.92M | 113.81M | 88.36M | 105.11M |
| Gross Profit | 57.83M | 159.88M | 130.17M | 123.43M | 152.51M |
| SG&A Expenses | -95.28M | 24.51M | 91.25M | 37.68M | 32.95M |
| Depreciation & Amortization | 5.19M | 5.00M | 5.25M | 5.09M | 5.28M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.76M | 137.44M | 210.31M | 131.13M | 143.34M |
| Operating Income | 147.92M | 130.37M | 33.68M | 80.66M | 114.28M |
| Income Before Tax | 25.89M | 123.94M | 23.73M | 71.22M | 108.66M |
| Income Tax Expenses | 9.29M | 27.14M | 7.59M | 20.41M | 9.15M |
| Earnings from Continuing Operations | 16.61M | 96.80M | 16.14M | 50.81M | 99.50M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -4.77M | -41.36M | -33.84M | -29.59M | -37.89M |
| Net Income | 11.83M | 55.44M | -17.70M | 21.22M | 61.61M |
| EBIT | 147.92M | 130.37M | 33.68M | 80.66M | 114.28M |
| EBITDA | 153.11M | 135.37M | 38.93M | 85.75M | 119.56M |
| EPS Basic | 1.67 | 8.27 | -2.95 | 3.74 | 11.81 |
| Normalized Basic EPS | 11.96 | 5.39 | -3.17 | 2.63 | 5.75 |
| EPS Diluted | 1.56 | 7.76 | -2.95 | 3.16 | 11.31 |
| Normalized Diluted EPS | 11.96 | 5.03 | -3.17 | 2.23 | 5.41 |
| Average Basic Shares Outstanding | 7.07M | 6.70M | 5.99M | 5.67M | 5.22M |
| Average Diluted Shares Outstanding | 7.07M | 7.18M | 5.99M | 6.70M | 5.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | 34.71% | -- |